SMTL ID : 6eds.2 (1 other biounit)

Structure of Cysteine-free Human Insulin-Degrading Enzyme in complex with Glucagon and Substrate-selective Macrocyclic Inhibitor 63

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.18 Å

Oligo State

hetero-1-1-mer

Ligands

1 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)

EPE.1: 11 residues within 4Å: Chain A: Q.759, N.764, R.798, A.799, N.800, G.801, G.868, E.869, S.872, Q.874, R.879 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Q.759, A:R.798, A:N.800, A:G.801 Salt bridges: A:E.869

1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.2: 10 residues within 4Å: Chain A: L.497, L.533, N.594, Q.597, P.598, N.691, I.692, T.693, A.696, I.700 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.597, A:T.693

1 x DIO: 1,4-DIETHYLENE DIOXIDE(Non-covalent)

DIO.3: 4 residues within 4Å: Chain A: E.488, F.489, Y.566, I.599 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Y.566

1 x J22: {(8R,9S,10S)-9-(2',3'-dimethyl[1,1'-biphenyl]-4-yl)-6-[(1-methyl-1H-imidazol-2-yl)sulfonyl]-1,6-diazabicyclo[6.2.0]decan-10-yl}methanol(Non-covalent)

J22.4: 22 residues within 4Å: Chain A: A.157, L.160, F.161, L.163, E.164, T.167, Y.261, I.263, Y.273, T.275, V.319, G.320, G.321, Q.322, K.323, I.333, N.335, R.436, A.438 Chain B: Q.3, T.5, F.22 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.160, A:E.164, A:Y.261, A:Y.261, A:Y.273, A:Y.273, A:Y.273, A:I.333, A:A.438 Hydrogen bonds: A:N.335

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Maianti, J.P. et al., Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme. Nat.Chem.Biol. (2019)

Release Date

2019-04-03

Peptides

Insulin-degrading enzyme: A
Glucagon: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
D

Insulin-degrading enzyme

Glucagon

Related Entries With Identical Sequence